Subscribe

ProShares Ultra Nasdaq Biotechnology (BIB)

USD99.88 -3.04 (-2.95%)
NASDAQ USD US Equity
NAV USD 102.88 -2.92% vs NAV as of 2026-07-13
AUM USD 86.42M
TER 1.19%
Yield (TTM) 0.32%
Distribution Distributing · Quarterly
52-week range 48.60 – 109.84
Holdings 260
Issuer ProShares

About this ETF

ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.

ISIN US74347R2141
Issuer ProShares
Domicile US
Inception 2010-04-07
Asset class Equity

Price

Top 10 holdings

Net Other Assets (Liabilities) 38.17%
PROSHARES GENIUS MNY MKT ETF IQMM 5.79%
VERTEX PHARMACEUTICALS INC VRTX 4.40%
AMGEN INC AMGN 4.38%
GILEAD SCIENCES INC GILD 3.92%
REGENERON PHARMACEUTICALS REGN 2.65%
ALNYLAM PHARMACEUTICALS INC ALNY 1.54%
REVOLUTION MEDICINES INC RVMD 1.54%
BIOGEN INC BIIB 1.14%
ILLUMINA INC ILMN 1.11%
See full holdings →